Morning Overview on MSN
A blood test caught 90% of aggressive prostate cancers, against 74% for the standard PSA
The standard PSA test has anchored prostate cancer screening for decades, but it has a well-known weakness: it flags plenty ...
Add Yahoo as a preferred source to see more of our stories on Google. b' Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023 ...
Annual check-ups save lives by detecting prostate issues early, yet many men avoid these crucial tests due to fear or misconceptions. Prostate health significantly impacts overall well-being, making ...
The Queen Zone on MSN
New blood test could help spot aggressive prostate cancer earlier
For many men, a prostate cancer scare starts with one number. A PSA result comes back high, and ...
The Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...
Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in certain cases. Active surveillance is increasingly chosen for favorable ...
An updated Cochrane review has found that prostate-specific antigen (PSA) screening probably reduces deaths from prostate cancer — a notable shift from the influential group’s 2013 conclusion that ...
The Stockholm3 model combines PSA, plasma protein biomarkers, polygenic risk, and clinical factors for prostate cancer screening.
Black individuals in the United States continue to experience the highest rates of prostate cancer diagnosis and death. Even though the prostate-specific antigen (PSA) test, a validated diagnostic ...
Frequent nighttime urination and persistent urinary changes may signal prostate cancer, making early PSA screening and timely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results